Deoxycholic acid vs cryolipolysis for under-chin fullness
Under-chin fullness may involve fat, loose skin or other anatomy. Deoxycholic acid injection and cryolipolysis both appear on treatment menus, but their mechanisms and authorized uses differ. The first decision is whether the fullness is the kind of fat these approaches can appropriately target.
The key differences
| What to compare | Deoxycholic acid injection | Cryolipolysis |
|---|---|---|
| Method | Medicine that disrupts cells | Controlled external cooling |
| Site check | US approved use is submental fat in adults | Exact device and applicator for the chin |
| Early appearance | Swelling can obscure contour change | Tenderness or swelling can occur |
| Distinct risk | Nerve injury, swallowing problems or persistent masses | Cold injury or paradoxical fat enlargement |
| Shared limitation | Does not treat every cause of neck fullness | Does not treat every cause of neck fullness |
Assess the chin and neck together
Ask whether fat is the main cause and how skin laxity or structural features affect the contour. A fat-reduction procedure cannot be assumed to correct everything visible under the chin. If fullness is unexplained or changing, it needs assessment before cosmetic treatment. Define the change you want rather than choosing by the phrase fat dissolving.
What deoxycholic acid does
Deoxycholic acid disrupts cells and is administered as a medicine. In the United States, approved injections address moderate-to-severe fullness from submental fat in adults. Kybella is one identifiable product example, not a generic name for all lipolytic mixtures. The exact formulation, approved site and suitability need verification rather than a broad injection-menu description.
What cryolipolysis does
Cryolipolysis uses controlled cooling through an external applicator. An under-chin proposal needs a device and applicator intended for that region. Findings from abdominal treatment do not establish the result for the chin. Ask whether the fat pocket can be treated adequately and what improvement is realistic in the presence of loose skin.
Keep the current drug warning explicit
The FDA September 2026 communication recommends against deoxycholic acid use outside the submental region because that use is unapproved and serious adverse reactions have occurred. Persistent injection-site nodules or masses can occur even with indicated under-chin treatment. These United States statements do not establish authorization in another country; the local product status needs its own check.
Compare different complication patterns
Deoxycholic acid can cause swelling, bruising, nerve injury, difficulty swallowing or tissue injury. Cryolipolysis can cause cold injury or numbness and paradoxical fat enlargement that may require surgery. Ask about medical conditions affected by cold, previous neck treatment and follow-up for persistent lumps or an uneven smile. New swallowing problems or other concerning reactions need medical assessment.
Plan for delayed contour assessment
Injection swelling can make the area look fuller before a settled result is judged. Cooling-related change also develops over time. Discuss visible downtime, work or exercise restrictions and the final assessment interval separately. Compare the planned course and total cost including review. A non-surgical approach still requires a credible response if improvement is limited or complications develop.
Common questions
Can deoxycholic acid treat abdominal fat?
The FDA recommends against use outside the submental region. Do not assume a fat-dissolving label establishes an appropriate body use.
Is cooling automatically better for the chin?
No. Suitability depends on the device, applicator, fat pocket, cold-related health conditions and the intended contour change.
What if the main problem is loose neck skin?
Fat reduction may leave that concern unresolved. Ask for a separate laxity assessment before deciding on either approach.
Read the original sources
Sources describe specific products, studies or countries. They do not establish approval everywhere.
General education. Your clinician can assess your individual suitability. Rules depend on the treatment country; FDA references concern the United States. External sources may be in another language.